Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + mBU/CY Conditioning for R/R Acute Leukemia HSCT
NCT03799224Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute leukemia, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT03799224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799224.